Aillis is an AI-powered medical device for early and accurate influenza detection in the development of innovative medical devices.
Aillis has raised $3.3M in total funding. The most recent round was Series D. The last funding was announced in November 2024.
Aillis's investors include Nissay Capital, MITSUI SUMITOMO INSURANCE Venture Capital (MSIVC), Beyond Next Ventures, Pegasus Tech Ventures, Shionogi.
Aillis is headquartered in Tokyo, Japan.
Aillis is an AI-powered medical device for early and accurate influenza detection in the development of innovative medical devices.
Aillis is at the Series D stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Aillis — Funding & Investors." VCBacked, November 29, 2024, https://www.vcbacked.co/company/aillis. Accessed October 30, 2026.
VCBacked. (2024). Aillis — Funding & Investors. Retrieved October 30, 2026, from https://www.vcbacked.co/company/aillis
{{cite web |title=Aillis — Funding & Investors |url=https://www.vcbacked.co/company/aillis |website=VCBacked |access-date=October 30, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated